Format

Send to

Choose Destination
Curr Urol. 2017 Aug;10(3):154-156. doi: 10.1159/000447171. Epub 2017 Jul 30.

Kenalog Injection into Hunner's Lesions as a Treatment for Interstitial Cystitis/Bladder Pain Syndrome.

Author information

1
Division of Female Pelvic Medicine and Reconstruction, Drexel University College of Medicine, Philadephia, Pennsylvania, USA.

Abstract

INTRODUCTION:

This study aims to evaluate the effectiveness of kenalog injection into Hunner's lesions.

MATERIALS AND METHODS:

All patients had cystoscopy and bladder hydrodistention with corticosteroid injection into Hunner's lesions over a 2.5-year period. Data include patient characteristics and pre- and post-operative validated questionnaires. Spearman Correlation and Wilcoxon t-tests were used for analysis.

RESULTS:

One hundred patients were reviewed retrospectively. There was a 1.1 point decrease in pain at 12 weeks post-operation (p = 0.435). Urinary frequency decreased from a mean of 11.7 to 9.1 daily episodes (p = 0.05), and nocturia from a mean of 3 to 1.6 nightly episodes (p = 0.008).

CONCLUSION:

The use of a corticosteroid may be beneficial to symptom control and improvement in the quality of life of interstitial cystitis/painful bladder syndrome patients. Patients had improved frequency and nocturia 12 weeks post injection.

KEYWORDS:

Hunner's lesions; Interstitial cystitis; Kenalog; Painful bladder syndrome

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland Icon for PubMed Central
Loading ...
Support Center